Table 2.
Age-standardized female breast cancer disability (DALYs) in relation to bioclinical factors and breast cancer screening programmes
Coefficient | 95% CI | |
---|---|---|
Cardiovascular diseases | 0.004 | −0.00 to 0.01 |
Diabetes and kidney diseases | 0.07 | 0.06 to 0.08 |
Neoplasms | 0.08 | 0.06 to 0.10 |
High LDL-c | 23.72 | 19.58 to 27.87 |
Smoking | 42.94 | 37.22 to 48.67 |
Secondary smoke | −0.89 | −1.71 to −0.07 |
High BMI | 2.81 | 0.62 to 5.00 |
Only SBE/CBE tests | Reference | |
MM and/or SBE/CBE tests | −91.27 | −158.17 to −24.37 |
DMM/US and/or the previous tests | −81.31 | −156.06 to −6.56 |
No country/pilot screening programmea | Reference | |
Regional-wise screening programme | −51.37 | −141.65 to 38.92 |
National-wise screening programme | −91.15 | −186.32 to 4.02 |
Cardiovascular diseases, diabetes and kidney disease, and neoplasms are expressed as age-standardized disability adjusted years of life. Neoplasms estimates exclude breast cancer. High LDL-c, smoking, secondary smoke and high BMI are expressed as age-standardized summary exposure values (SEVs; range 0-100).
95 CIs, 95% confidence intervals; BMI, body mass index; CBE, clinical breast examination; DMM, digital mammography; DMM/US, digital mammography and/or ultrasound; LDL-c, low-density lipoprotein-cholesterol; MM, mammography; SBE, self-breast examination; SBE/CBE tests, self-breast and/or clinical breast examination; SEV, summary exposure value; US, ultrasound.
No country programme or existence of an opportunistic or pilot screening programme.